[EN] FUSED HETEROARYL COMPOUNDS USEFUL AS ANTICANCER AGENTS<br/>[FR] COMPOSÉS HÉTÉROARYLE FUSIONNÉS UTILES EN TANT QU'AGENTS ANTICANCÉREUX
申请人:[en]KUMQUAT BIOSCIENCES INC.
公开号:WO2022266015A1
公开(公告)日:2022-12-22
The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.